Accession Number: | 0001453687-23-000015 |
Date: | 2023-01-02 |
Issuer: | SELECTA BIOSCIENCES INC (SELB) |
Original Submission Date: |
TRABER PETER G
C/O SELECTA BIOSCIENCES, INC.
65 GROVE STREET
WATERTOWN, MA 02472
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2023-01-02 | A | 200,000 | a | $0.00 | 457,765 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 1.13 | 2023-01-02 | deemed execution date | A | 900,000 (a) | 2033-01-01 | common stock 900,000 | $1.13 | 900,000 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents a contingent right to receive one share of common stock, which will vest as to 25% on january 2, 2024. the remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on january 2, 2027. |
f2 | includes 6,410 shares of common stock purchased under the issuer's employee stock purchase program during the contribution period between march 1, 2022 and august 31, 2022. |
f3 | this option vests as to 25% on january 2, 2024. the remainder of the underlying shares will vest in 36 equal monthly installments thereafter. |